Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy

Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma

(2015) Bing Zheng et al.   CANCER LETTERS

The Generation R Study: Biobank update 2015

(2014) Claudia J. Kruithof et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

(2014) Bo Mi Ku et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Autophagy-Mediated Tumor Promotion

(2013) Jessie Yanxiang Guo et al.   CELL

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

(2013) Bo Mi Ku et al.   FASEB JOURNAL

Comprehensive molecular characterization of clear cell renal cell carcinoma

(2013)   NATURE

Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser

(2013) Melissa S. Cline et al.   Scientific Reports

Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins

(2012) M D'Eletto et al.   CELL DEATH AND DIFFERENTIATION

Therapeutic targets in cancer cell metabolism and autophagy

(2012) Heesun Cheong et al.   NATURE BIOTECHNOLOGY

p62: a versatile multitasker takes on cancer

(2012) Jorge Moscat et al.   TRENDS IN BIOCHEMICAL SCIENCES

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

(2011) Bo Li et al.   BMC BIOINFORMATICS

Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate

(2010) Byeong-Gu Han et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro

(2010) Ullén   INTERNATIONAL JOURNAL OF ONCOLOGY

Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes

(2008) P. K. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA